Cargando…

Continued Exploration of Bevacizumab in Breast Cancer

Detalles Bibliográficos
Autores principales: Mehta, Rita S., Su, Min-Ying
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816792/
https://www.ncbi.nlm.nih.gov/pubmed/19936837
http://dx.doi.org/10.1245/s10434-009-0835-4
_version_ 1782177132088131584
author Mehta, Rita S.
Su, Min-Ying
author_facet Mehta, Rita S.
Su, Min-Ying
author_sort Mehta, Rita S.
collection PubMed
description
format Text
id pubmed-2816792
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-28167922010-02-13 Continued Exploration of Bevacizumab in Breast Cancer Mehta, Rita S. Su, Min-Ying Ann Surg Oncol Breast Oncology Springer-Verlag 2009-11-21 2010 /pmc/articles/PMC2816792/ /pubmed/19936837 http://dx.doi.org/10.1245/s10434-009-0835-4 Text en © The Author(s) 2009 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Breast Oncology
Mehta, Rita S.
Su, Min-Ying
Continued Exploration of Bevacizumab in Breast Cancer
title Continued Exploration of Bevacizumab in Breast Cancer
title_full Continued Exploration of Bevacizumab in Breast Cancer
title_fullStr Continued Exploration of Bevacizumab in Breast Cancer
title_full_unstemmed Continued Exploration of Bevacizumab in Breast Cancer
title_short Continued Exploration of Bevacizumab in Breast Cancer
title_sort continued exploration of bevacizumab in breast cancer
topic Breast Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816792/
https://www.ncbi.nlm.nih.gov/pubmed/19936837
http://dx.doi.org/10.1245/s10434-009-0835-4
work_keys_str_mv AT mehtaritas continuedexplorationofbevacizumabinbreastcancer
AT suminying continuedexplorationofbevacizumabinbreastcancer